Newsroom | 585 results

Sorted by: Latest

Patent Law
-

Calcium Carbonate Market Demand and Competition Outlook Report 2025-2033 - Emerging Opportunities in Pharmaceuticals and Coatings Boost Market Potential - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Calcium Carbonate Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global calcium carbonate market, valued at USD 34.4 billion in 2024, is projected to reach USD 70.1 billion by 2033, with an impressive CAGR of 8.3% from 2025 to 2033. The market's steady expansion is attributed to industries increasingly opting for versatile, cost-effective raw materials. Key producers focus on optimizing particle size distribution, surface treatmen...
-

Cumene (CAS 98-82-8) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Pricing, Manufacturers, End-Users, and Downstream Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cumene (CAS 98-82-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Cumene provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understanding the...
-

Methylamine (CAS 74-89-5) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Pricing, Manufacturers, End-Users, and Downstream Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Methylamine (CAS 74-89-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Methylamine provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for underst...
-

Chloroform (CAS 67-66-3) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Applications, Pricing, Manufacturers, End-Users, and Downstream Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Chloroform (CAS 67-66-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Chloroform provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understan...
-

Phenindione (CAS 83-12-5) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Applications, Pricing, Manufacturers, End-Users, and Downstream Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Phenindione (CAS 83-12-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Phenindione provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for underst...
-

Phenformin (CAS 114-86-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Phenformin (CAS 114-86-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Phenformin provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understa...
-

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new composition of matter patent covering PGN-EDODM1, which leverages PepGen’s proprietary Enhanced Delivery Oligonucleotide (EDO) platform, including it...
-

Universal Display Corporation to Acquire Emissive OLED Patent Assets from Merck KGaA, Darmstadt, Germany

EWING, N.J.--(BUSINESS WIRE)--UDC today announced that it has entered into a definitive agreement to acquire OLED patent assets from Merck KGaA, Darmstadt, Germany....
-

UDC宣布收购德国默克集团OLED发光专利资产

美国新泽西州尤英市--(BUSINESS WIRE)--(美国商业资讯)-- Universal Display Corporation,(纳斯达克股票代码:OLED,以下简称UDC)今日宣布,公司已与位于德国达姆施塔特的默克集团(Merck)达成最终协议,将收购其部分OLED发光材料相关专利资产。 此次收购的专利组合平均剩余有效期约10年,在全球范围内拥有超过300项已授权和待审批专利,涉及110多个独特的专利群组,主要集中于先进的OLED发光器件结构及相关材料器件。这项交易预计将扩展UDC在关键发光材料领域的专利覆盖范围,从而提升高效率OLED器件的技术优势。 UDC总裁兼首席执行官Steven V. Abramson 表示: “我们很高兴能继续强化OLED专利组合,该举措将有助于提升UDC的OLED技术路线图,并进一步拓展我们的创新版图。来自德国默克集团的这些专利资产预计将与我们世界级的研发与材料设计平台形成强力互补。” 德国默克集团OLED业务总经理Johannes Canisius补充道:“此次知识产权交易标志着默克在发光层技术创新中取得了重要成果。将其专利转让给UDC,在实...
-

Tulyp Medical Emerges From Sofinnova’s Medtech Accelerator and Announces FDA Submission Following Initial First-in-Human Use

PARIS--(BUSINESS WIRE)--Tulyp Medical, a Paris-based startup developing a medical device for intelligent pressure-driven perfusion, emerged from stealth and announced it has submitted its 510(k) application to the U.S. Food and Drug Administration (FDA). The company’s debut follows positive results from its initial first-in-human study. Tulyp is led by Mano Iyer, Partner at Sofinnova Partners and a serial medtech entrepreneur, who serves as Chief Executive Officer. Tim Lenihan, co-founder and C...